Q1 2024 Holdings
Filed 2024-05-15 | 49 holdings | $497.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & CoPut | PUT | 532457958 | $89.5M | 115,000 | 18.0% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $88.8M | 691,743 | 17.9% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $72.0M | 92,593 | 14.5% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $50.0M | 379,200 | 10.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $35.6M | 433,580 | 7.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $16.5M | 90,821 | 3.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $14.5M | 210,096 | 2.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $13.5M | 34,238 | 2.7% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $12.9M | 190,752 | 2.6% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $12.1M | 28,900 | 2.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.0M | 87,848 | 1.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $6.6M | 724,685 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.3M | 89,525 | 1.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $6.2M | 45,000 | 1.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $5.4M | 87,040 | 1.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.2M | 76,255 | 1.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $4.1M | 61,590 | 0.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $4.0M | 85,765 | 0.8% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $3.6M | 124,440 | 0.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $3.4M | 119,488 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $3.2M | 118,236 | 0.6% |
| Springworks Therapeutics Inc | COM | 85205L107 | $2.7M | 53,930 | 0.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.4M | 15,894 | 0.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $2.3M | 52,492 | 0.5% |
| Merus N V | COM | N5749R100 | $2.3M | 50,171 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $2.1M | 130,790 | 0.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $2.0M | 51,714 | 0.4% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $1.9M | 6,905 | 0.4% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $1.8M | 47,949 | 0.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $1.8M | 40,924 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.7M | 40,000 | 0.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $1.7M | 40,000 | 0.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $1.5M | 100,000 | 0.3% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.4M | 421,359 | 0.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.3M | 54,285 | 0.3% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $1.2M | 137,308 | 0.2% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $1.1M | 52,476 | 0.2% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $1.1M | 51,500 | 0.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $1.1M | 147,485 | 0.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $1.0M | 24,298 | 0.2% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $942.2K | 64,007 | 0.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $842.1K | 39,478 | 0.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $691.3K | 21,397 | 0.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $530.0K | 35,452 | 0.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $441.7K | 58,190 | 0.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $415.8K | 1,557 | 0.1% |
| Effector Therapeutics IncCall | CALL | 28202V907 | $359.8K | 25,000 | 0.1% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $274.3K | 86,002 | 0.1% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $244.6K | 95,170 | 0.0% |